Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Lorus Therapeutics Inc New T.LOR

Sector: Healthcare | Sub-Sector: Biotechnology

Lorus Therapeutics Inc is a clinical stage biotechnology company. It is engaged in discovering and developing targeted therapies addressing unmet medical needs in oncology.
Price: $0.475 | Change: +$0.01 | %Change: +2.15%
Volume: 198,633 | Day High/Low: 0.485/0.46 | 52 Week High/Low: 1.04/0.17

Snapshot

Last Traded: July 22, 2014 12:00 Transaction Volume: 198,633
Open: $0.475 Previous Close: $0.465
Bid: $0.46 Ask: $0.475
Bid Size: 27,500 Ask Size: 48,500
Market Cap: $66.2m Shares Out: 139.3m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Pinetree Capital's three favourite 'high potential tech plays'

Tommy Humphreys   February 3, 2014
0 stars

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Mystery Movers: Biomed shares surging, triple digit rises all over, executives baffled

When you're standing on a launchpad and a rocket is taking off, the best place to be is on the rocket.

Chris Parry   November 19, 2013
0 stars

Mystery Movers: Spectral Diagnostics jumps 22% as Canadian biotech goes viral

You're still looking for rocks in the ground? Get with the program: Biotech is booming.

Chris Parry   November 5, 2013
0 stars

Latest Bullboard Posts